Exchange: NYSEArca·Updated 03:01 AM EST

IWM News

News
all
press releases
ANT Stock’s $1.5T Debut Won’t Immediately Move The Needle For Nasdaq, S&P 500, Says Morningstar — Here’s Why
Morningstar sees the initial impact of Anthropic’s listing on most indexes to be modest, as only about 6% of the company’s shares will be up for trading.
Stocktwits
ANT Stock’s $1.5T Debut Won’t Immediately Move The Needle For Nasdaq, S&P 500, Says Morningstar — Here’s Why
Morningstar sees the initial impact of Anthropic’s listing on most indexes to be modest, as only about 6% of the company’s shares will be up for trading.
Stocktwits
More News
CEO Demopulos said the company is now shifting its near-term regulatory strategy outside the European Union.
Stocktwits
Strive keeps around 85% to 90% of its balance sheet in Bitcoin and 10% to 15% in cash, which can cover its obligations during a downturn, the CEO said.
Stocktwits
Core Scientific stated that it is transitioning its remaining mining facilities to colocation locations as fast as possible.
Stocktwits
Founder and CEO JoeBen Bevirt said the company made “important progress on the fifth and final stage of certification, completing a wide range of ‘for credit’ testing with the FAA.”
Stocktwits
Paris-headquartered Sanofi notified Nurix on Tuesday that it is ending the early-stage first-in-human trial of SAR448272 and terminating the program entirely.
Stocktwits
Sanofi notified Nurix that it is ending the early-stage first-in-human trial of SAR448272 and terminating the program entirely.
Stocktwits
LS Power Equity Advisors has put forth a non-binding proposal to buy the Class A shares of EVgo that it does not already own for $2 in cash.
Stocktwits
In trading on Friday, shares of the iShares Russell 2000 ETF (Symbol: IWM) crossed below their 200 day moving average of $278.64, changing hands as low as $276.91 per share. iShares Russell 2000 shares are currently trading off about 2.2% on the day. The chart below shows the...
Nasdaq News: Markets
Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S. District Court for the District of Columbia against the FDA and related federal defendants.
Stocktwits

Advertisement|Remove ads.